Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 15, 2018

SELL
$14.05 - $20.2 $150,335 - $216,140
-10,700 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$12.85 - $18.1 $1,285 - $1,810
100 Added 0.94%
10,700 $163,000
Q3 2017

Nov 13, 2017

BUY
$15.4 - $18.85 $163,240 - $199,810
10,600
10,600 $190,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $264M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.